Add like
Add dislike
Add to saved papers

Friends or foes? Monetized Life Cycle Assessment and Cost-Benefit Analysis of the site remediation of a former gas plant.

Site contamination is a global concern because of the potential risks for human health and ecosystem quality. Every contaminated site has its own specific characteristics and the increased availability and efficiency of remediation techniques makes the choice of remediation alternative increasingly complicated. In this paper an attributional Life Cycle Assessment (LCA) of the secondary environmental impacts of a site remediation is performed and its results are monetized using two different monetization techniques, namely Stepwise 2006 and Ecovalue 08. Secondly, we perform a social Cost-Benefit Analysis (CBA) on the same case study using the same data sources. The case study used in this paper entails the soil and groundwater remediation of a tar, poly-aromatic hydrocarbons (PAH) and cyanide contamination of a school ground by a former gas plant. The remediation alternative chosen in this case study is excavation with off-site thermal treatment of the contaminated soil. The outcome of the social CBA, stating that the remediation project is socially beneficial in the long term, is critically compared to the outcome of the different LCA monetization methods. This comparison indicates that monetized LCA is a good complement to social CBA when it comes to the assessment of secondary environmental impacts. Combining the two methods provides decision makers with a more extensive and detailed assessment of the soil remediation project.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app